Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway
Ying Li, Lei Wang, Tianyue Guan, Yaru Chen, Wenting Zhu, Xiao Liu, Yusa Li, Hongyu Huang, Zibo Dong, Honggang Zhang · 2025
Read Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway by Ying Li, Lei Wang, Tianyue Guan, Yaru Chen, Wenting Zhu, Xiao Liu, Yusa Li, Hongyu Huang, Zibo Dong, Honggang Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12823695.txt.
Description
Ying Li and co-authors tested a natural plant compound as a treatment for heart damage caused by diabetes, in work published in 2025. The disease stiffens and weakens the heart through swelling, cell stress, scarring, and cell death. Mice were made diabetic and then given the compound.
Treated mice showed less heart injury and less swelling, stress, scarring, and cell death. The same gains appeared in heart cells exposed to high sugar in the lab. The compound acted by blocking a protein switch that drives a growth signal path. When a known blocker of that switch was added, the benefit vanished, which supports the claimed route. The authors propose the compound as a lead for new treatments.
Catalog record
| CREATOR | Ying Li, Lei Wang, Tianyue Guan, Yaru Chen, Wenting Zhu, Xiao Liu, Yusa Li, Hongyu Huang, Zibo Dong, Honggang Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |